HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lubo Merkov Selected Research

1-(N-diphenylacetamido)-2-butanol

1/20024-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lubo Merkov Research Topics

Disease

1Multiple Sclerosis
12/2016
1Leukemia
01/2002

Drug/Important Bio-Agent (IBA)

1Interferon beta-1b (Betaseron)FDA Link
12/2016
1Retinaldehyde (Retinal)IBA
01/2002
11-(N-diphenylacetamido)-2-butanolIBA
01/2002
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2002
14-(N,N-dipropylamino)benzaldehydeIBA
01/2002

Therapy/Procedure

1Therapeutics
12/2016